“We are building to be one of the fastest-growing companies by the end of the decade,” says Chris Boerner, CEO, Bristol Myers Squibb. In an exclusive interaction with ET Prime, Boerner discusses the company’s focus on AI, why it is an exciting time to be in the oncology space, and their growing presence in India.